FAQs
PERTUSSIS: A Physician's Quick References Guide
Prescribing Information
Important Safety Information
Material Safety Data Sheet
STEPP Compliance Program
Important Safety Information
In clinical studies, adverse events in adolescents receiving BOOSTRIX included pain, redness, and swelling at the injection site, headache, fatigue and gastrointestinal symptoms. As with other vaccines, rare adverse events may occur.

Adverse events in children receiving INFANRIX included injection-site reactions (erythema, swelling, and tenderness), fever, irritability, and drowsiness.

As with any vaccine, vaccination with BOOSTRIX or INFANRIX may not protect 100% of susceptible individuals. Hypersensitivity to any component of BOOSTRIX or INFANRIX is a contraindication.




Home   FAQs   Pertussis Information   BOOSTRIX Prescribing Information  
Important Safety Information   Material Safety Data Sheet   STEPP Compliance Program

This site is intended for US healthcare professionals only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us


Manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium
Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709